Essential role of AT1A receptor in the development of 2K1C hypertension

Hypertension

Volumn 40, Issue 5, 2002, Pages 735-741

  Červenka, Luděk ^a   Horáček, Vladislav ^a   Vaněčková, Ivana ^a   Hubáček, Jaroslav A ^a   Oliverio, Michael I ^a   Coffman, Thomas M ^a   Navar, L Gabriel ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Hypertension, renovascular; Mice; Nitric oxide; Nitric oxide synthase; Receptors, angiotensin II

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; KNOCKOUT MOUSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENAL ARTERY; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART MUSCLE; KIDNEY; METABOLISM; MOUSE MUTANT; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME INHIBITORS; HYPERTENSION, RENOVASCULAR; IMIDAZOLES; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE SYNTHASE; ORGAN SIZE; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 0036827030     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000036452.28493.74     Document Type: Article

References (40)

1. Navar LG, Zou L, Von Thun A, Wang CT, Imig JD, Mitchell KD. Unraveling the mystery of Goldblatt hypertension. News Physiol Sci. 1998;13:170-176.
2. Chatziantoniou C, Arendshorst WJ. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol. 1993;259:F372-F382.
3. Mitchell KD, Mullins JJ. ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am J Physiol. 1995;268:F821-F828.
4. 1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension. 1999;33:102-107.
5. Sasamura H, Hein L, Krieger J, Pratt R, Kobilka B, Dzau V. Cloning characterization and expression of 2 angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun. 1992;185:253-259.
6. Bouby N, Hus-Citharel A, Marchetti J, Bankir L, Corvol P, Llorens-Cortes C. Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol. 1997;8:1658-1667.
7. Burson J, Aguilera G, Gross K, Sigmund C. Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol. 1994;267:E260-E267.
8. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92:3521-3525.
9. 1A receptor knockout mouse during normal and volume-expanded conditions. Kidney Int. 1999;56:1855-1862.
10. 1A receptor for angiotensin II. Hypertension. 2000;35:550-554.
11. Oliverio MI, Delnomdedieu M, Best CF, Li P, Morris M, Callahan MF, Johnson CA, Smithies O, Coffman TM. Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. Am J Physiol. 2000;278:F75-F82.
12. Chen X, Li W, Yoshida H. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol. 1997;272:F299-F304.
13. 1B receptors in blood pressure regulation. Am J Physiol. 1997;272:F515-F520.
14. Ruan X, Purdy KE, Oliverio MI, Coffman TM, Arendshorst WJ. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice. J Am Soc Nephrol. 1999;10:S202-S207.
15. 1A receptor-deficient mice. Hypertension. 1998;31:1171-1177.
16. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2001;52:11-34.
17. Coffman TM. Gene targeting in physiological investigations: Studies of the renin-angiotensin system. Am J Physiol. 1998;274:F999-F1005.
18. 1A receptors for angiotensin II. Am J Physiol. 1998;274:F43-F48.
19. 1A receptor. Hypertension. 1999;33:482-486.
20. Dedeoglu IO, Springate JE. Effect of nitric oxide inhibition on kidney function in experimental renovascular hypertension. Clin Exp Hypertens. 2001;23:267-275.
21. Chin SY, Wang CT, Majid DSA, Navar LG. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Am J Physiol. 1998;274:F876-F882.
22. Navar LG, Ichihara A, Chin SY, Imig JD. Nitric oxide-angiotensin II interactions in angiotensin II-dependent hypertension. Acta Physiol Scand. 2000;168:139-147.
23. Blume A, Kaschina E, Unger T. Angiotensin II type 2 receptors: Signaling and pathophysiological role. Curr Opin Nephrol Hypertens. 2001;10:239-246.
24. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip, and one-kidney, one clip hypertension in mice. Hypertension. 1997;29:1025-1030.
25. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996;98:418-425.
26. 2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension. 1998;31:487-492.
27. Macari D, Whitebread S, Cumin F, DeGasparo M, Levens N. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur J Pharmacol. 1994;259:27-36.
28. 2 receptor knockout mice. Hypertension. 2001;37:967-973.
29. Nishimura H, Matsusaka T, Fogo A, Kon V, Ichikawa I. A novel in vivo mechanism for angiotensin type 1 receptor regulation. Kidney Int. 1997;52:345-355.
30. Thorup C, Kornfeld M, Wivaver JM, Goligorskz MS, Moore LC. Angiotensin II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflugers Arch. 1998;435:432-434.
31. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrate in endothelial cells. Am J Physiol. 1998;274:C214-C220.
32. 1 receptor antagonist in hypertensive rats. Hypertension. 1999;34:1112-1116.
33. Carey RM, Howell NL, Jin XH, Siragy HM. Angiotensin type 2 receptor-mediated hypotension in angiotensin type 1 receptor-blocked rats. Hypertension. 2001;38:1272-1277.
34. 2 receptor in a renal wrap hypertension model. Hypertension. 1999;33:1237-1242.
35. 2) angiotensin receptor. Proc Nat Acad Sci U S A. 1999;96:6505-6510.
36. Moore AF, Heiderstadt NT, Huang E, Howell NL, Wang ZQ, Siragy HM, Carey RM. Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats. Hypertension. 2001;37:1285-1291.
37. 2) angiotensin receptor. Acta Physiol Scand. 2000;168:65-71.
38. 2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension. 1998;31:487-492.
39. 2 receptor on hypertension development in young and adult SHR. Physiol Res. 1999;48:259-265.
40. Schuijt MP, Vries R, Saxena PR, Danser AHJ. No vasoactive role of the angiotensin II type 2 receptor in normotensive Wistar rats. J Hypertens. 1999;17:1879-1884.